BFC Planning’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
BFC Planning's INO Position: Q3 2026 in Review
BFC Planning increased its Inovio Pharmaceuticals (INO) stake by 1.3% in Q3 2026, buying an estimated $13 and bringing the position to 963 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #3137.
BFC Planning first reported a position in INO in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.5K in Q3 2024. 79 funds tracked by Wall St. Rank hold INO as of Q3 2026.
- BFC Planning held 963 shares of Inovio Pharmaceuticals worth $1.18K as of Q3 2026.
- BFC Planning bought 12 Inovio Pharmaceuticals shares in Q3 2026, an estimated $13.
- Inovio Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3137 holding.
- BFC Planning first reported a position in Inovio Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Inovio Pharmaceuticals position peaked at $5.5K in Q3 2024.
- 79 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.